The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment

Hong Zhou, Suhendan Ekmekcioglu, John W. Marks, Khalid A. Mohamedali, Kaushal Asrani, Keeley K. Phillips, Sharron A.N. Brown, Emily Cheng, Michele B. Weiss, Walter N. Hittelman, Nhan L. Tran, Hideo Yagita, Jeffrey A. Winkles, Michael G. Rosenblum

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds